About Us
BillionToOne is a pioneering biotechnology company driven by a mission to improve global healthcare through advanced molecular diagnostics. Our groundbreaking technology enables precise and cost-effective detection of genetic diseases and cancer mutations, revolutionizing diagnostic accuracy and patient care.
At BillionToOne, we combine cutting-edge science with a passion for innovation to develop solutions that empower clinicians and patients with actionable insights. Our proprietary tests provide unparalleled sensitivity and specificity, offering reliable results that inform personalized treatment decisions.
We are committed to pushing the boundaries of molecular diagnostics to address some of the most pressing healthcare challenges worldwide. By harnessing the power of genetics, we aim to transform healthcare delivery and improve outcomes for patients everywhere.
Join us in our journey to redefine diagnostics and make a meaningful impact on the future of healthcare.